For example, the combination of GFAP, EMA, S-100 and vimentin was used to assist epithelioid glioblastoma (Ep-GBM) which is one provisional new variant of glioblastoma added to the WHO 2016 classification [9]. This evidence concerns the gene S100A1 and glioblastoma.